Delic Holdings Corp.’s (CSE: DELC) (OTCQB: DELCF) Delic Labs to Present Latest Results and Insights from Its Extensive Experimental Studies on Cannabis Extraction at the Emerald Conference on February 28
- Delic Lab’s President and Chief Science Officer, Dr. Markus Roggen, will present at the upcoming Emerald Conference on February 28
- Delic Labs is a federally licensed research laboratory operating as part of the Delic Holdings ecosystem
- The laboratory focuses on extraction optimization, analytical testing, and chemical product and process development and is likely to continue supporting the cannabis industry with the latest technology and services as the cannabis market and cannabis extraction spaces mature
Delic Holdings (CSE: DELC) (OTCQB: DELCF) recently announced that Dr. Markus Roggen – the President and Chief Science Officer of Delic Labs, a federally licensed cannabis and psilocybin research laboratory operating as part of Delic’s ecosystem of wellness brands – will present at the 7th Annual Emerald Conference on Monday, February 28, 2022, at 12.45 pm PT (https://nnw.fm/zHw5c). The conference will be held at Loews Coronado Bay Resort in San Diego (https://nnw.fm/UCeFD).
Dr. Roggen’s presentation entitled “Artificial Intelligence for Craft Cannabis Products” will offer a unique opportunity for Delic Labs to report the latest results and insights from its comprehensive experimental studies.
“Focusing solely on extraction yields for cannabis extraction operations is an imprecise way to think about production,” commented Dr. Roggen. “Quality of extract, cost of extraction, and loss in post-processing should all be considered. Our laboratory undertook extensive experimental studies on the extraction behavior of various solvents, and we’re excited to present our latest results and insights from developing and utilizing our extraction optimization AI.”
As a research laboratory, Delic Labs focuses on extraction optimization, analytical testing, and chemical product and process development. In addition, the lab supports the psychedelic and cannabis industry with metabolomic identification, formulation research, process design and optimization, and high precision chemical analytics. Delic Labs also plans to develop a suite of novel compounds and delivery methods for the industry.
Dr. Roggen will be one of the more than 20 industry-leading speakers at the two-day event to be held at the Loews Coronado Bay Resort in San Diego (https://nnw.fm/Seq45). Considered the original, longest-running interdisciplinary cannabis science event, the Emerald Conference is expected to connect the scientific community through presentations, exhibitions, and networking opportunities.
Organizers have worked to ensure that this year’s conference will feature the latest research and emerging trends, issues, and opportunities. Little wonder, then, that Delic Labs is set to showcase results from its groundbreaking research on AI.
Through research, Delic Labs is innovating and subsequently pushing the boundaries of what is expected from cannabis extraction processes. And with multiple countries and states looking to legalize cannabis use in 2022, joining scores of trailblazers that have already decriminalized the substance, Dr. Roggen’s presentation and the results and insights he is set to share could not have come at a better time.
According to a Prohibition Partners report (https://nnw.fm/7Gd0s), the cannabis extraction space is set to evolve rapidly and become highly competitive as the global cannabis market matures and regulatory frameworks are established. “The ability and willingness of companies to leverage the latest technology and services in the cannabis extraction sector will mean the difference between their success, or failure, in the space,” the report reads.
Through its innovative approach to conducting research and the resulting discoveries, Delic Labs appears poised to continue supporting the cannabis industry with advanced technology and services as the cannabis market matures, providing the necessary innovation for companies to remain competitive and successful.
Since its founding in 2018, Delic has progressively built a robust ecosystem targeting psychedelic wellness. Its portfolio of brands currently includes the largest chain of ketamine clinics in the United States (Ketamine Wellness Centers), media platforms (Delic Radio and Reality Sandwich), a psychedelic wellness event (Meet Delic) and Delic Labs.
For more information, visit the company’s website at www.DelicCorp.com.
NOTE TO INVESTORS: The latest news and updates relating to DELCF are available in the company’s newsroom at https://nnw.fm/DELCF
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
- Delic Lab’s President and Chief Science Officer, Dr. Markus Roggen, will present at the upcoming Emerald Conference on February 28
- Delic Labs is a federally licensed research laboratory operating as part of the Delic Holdings ecosystem
- The laboratory focuses on extraction optimization, analytical testing, and chemical product and process development and is likely to continue supporting the cannabis industry with the latest technology and services as the cannabis market and cannabis extraction spaces mature
Delic Holdings (CSE: DELC) (OTCQB: DELCF) recently announced that Dr. Markus Roggen – the President and Chief Science Officer of Delic Labs, a federally licensed cannabis and psilocybin research laboratory operating as part of Delic’s ecosystem of wellness brands – will present at the 7th Annual Emerald Conference on Monday, February 28, 2022, at 12.45 pm PT (https://nnw.fm/zHw5c). The conference will be held at Loews Coronado Bay Resort in San Diego (https://nnw.fm/UCeFD).
Dr. Roggen’s presentation entitled “Artificial Intelligence for Craft Cannabis Products” will offer a unique opportunity for Delic Labs to report the latest results and insights from its comprehensive experimental studies.
“Focusing solely on extraction yields for cannabis extraction operations is an imprecise way to think about production,” commented Dr. Roggen. “Quality of extract, cost of extraction, and loss in post-processing should all be considered. Our laboratory undertook extensive experimental studies on the extraction behavior of various solvents, and we’re excited to present our latest results and insights from developing and utilizing our extraction optimization AI.”
As a research laboratory, Delic Labs focuses on extraction optimization, analytical testing, and chemical product and process development. In addition, the lab supports the psychedelic and cannabis industry with metabolomic identification, formulation research, process design and optimization, and high precision chemical analytics. Delic Labs also plans to develop a suite of novel compounds and delivery methods for the industry.
Dr. Roggen will be one of the more than 20 industry-leading speakers at the two-day event to be held at the Loews Coronado Bay Resort in San Diego (https://nnw.fm/Seq45). Considered the original, longest-running interdisciplinary cannabis science event, the Emerald Conference is expected to connect the scientific community through presentations, exhibitions, and networking opportunities.
Organizers have worked to ensure that this year’s conference will feature the latest research and emerging trends, issues, and opportunities. Little wonder, then, that Delic Labs is set to showcase results from its groundbreaking research on AI.
Through research, Delic Labs is innovating and subsequently pushing the boundaries of what is expected from cannabis extraction processes. And with multiple countries and states looking to legalize cannabis use in 2022, joining scores of trailblazers that have already decriminalized the substance, Dr. Roggen’s presentation and the results and insights he is set to share could not have come at a better time.
According to a Prohibition Partners report (https://nnw.fm/7Gd0s), the cannabis extraction space is set to evolve rapidly and become highly competitive as the global cannabis market matures and regulatory frameworks are established. “The ability and willingness of companies to leverage the latest technology and services in the cannabis extraction sector will mean the difference between their success, or failure, in the space,” the report reads.
Through its innovative approach to conducting research and the resulting discoveries, Delic Labs appears poised to continue supporting the cannabis industry with advanced technology and services as the cannabis market matures, providing the necessary innovation for companies to remain competitive and successful.
Since its founding in 2018, Delic has progressively built a robust ecosystem targeting psychedelic wellness. Its portfolio of brands currently includes the largest chain of ketamine clinics in the United States (Ketamine Wellness Centers), media platforms (Delic Radio and Reality Sandwich), a psychedelic wellness event (Meet Delic) and Delic Labs.
For more information, visit the company’s website at www.DelicCorp.com.
NOTE TO INVESTORS: The latest news and updates relating to DELCF are available in the company’s newsroom at https://nnw.fm/DELCF
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
